/ /

LATEST

Why Acanthamoeba diagnosis is often challengingHaving an awareness of current best practices—such as epidemiology, risk factors, signs and symptoms, and tests—can be key to identifying and treating corneal infections.
Transzonular intravitreal injection eases treatment burden after cataract surgery
Transzonular intravitreal injection eases treatment burden after cataract surgeryAn intraoperative injection of a compounded formulation of triamcinolone acetonide, moxifloxacin, and vancomycin eliminated the need for supplemental postoperative medications in the vast majority of patients who underwent phacoemulsification and IOL implantation.
Femtosecond laser use shows very low rate of capsule tears
Femtosecond laser use shows very low rate of capsule tears
Argon laser iridoplasty effective in occludable eyes treated with iridotomyArgon laser peripheral iridoplasty (ALPI) significantly widens the anterior chamber angle circumferentially in eyes with occludable angles treated with laser peripheral iridotomy, researchers say.
Introducing: Modern Retina
Introducing: Modern RetinaOphthalmology Times is pleased to introduce a new clinical and educational platform for retina specialists called Modern Retina.
‘Real-world’ ocriplasmin macular hole closure rates lag trialsOcriplasmin (Jetrea, ThromboGenics) may achieve lower macular hole closure rates than in trials, new British and Irish data suggests. Also, “the incidence of adverse events was greater than previously reported,” wrote RJ Haynes of Bristol Eye Hospital in Bristol, United Kingdom, and colleagues in the journal Eye.
Computer-based image analysis promising for ROPComputers may make more reliable diagnoses of plus disease in retinopathy of prematurity than individual clinicians, a researcher reports.
Paradigm shifting for ILM peeling, prone position after vitrectomyPeeling of the internal limiting membrane has increasingly become a dogma of surgical retina, while maintenance of the face-down positioning may become anachronistic in many cases.
New biomarker may predict treatment response in DMEResearchers have identified a new biomarker they believe can be used as a predictor of vision change in patients with diabetic macular edema, either during the natural history of the disease or after undergoing anti-VEGF therapy. The biomarker is disorganization of the retinal inner layers, or DRIL.
Multifocals show similar results but lower power offers better vision rangeBoth the Tecnis multifocal +2.75 D and +4.00 D IOLs had good visual results, but the +2.75 D IOL had a better range of vision across near, intermediate, and distance.

Poll

View Results